{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:20:26Z","timestamp":1791883226775,"version":"4.3.4"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ijbiomac.2023.124232","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T20:57:17Z","timestamp":1680123437000},"page":"124232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors"],"prefix":"10.1016","volume":"239","author":[{"given":"Aida","family":"Buza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-2789","authenticated-orcid":false,"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-4374","authenticated-orcid":false,"given":"Mustafa","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busra","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleta Rifati","family":"Nixha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.124232_bb0005","article-title":"Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors","author":"Lolak","year":"2022","journal-title":"Mol. Divers."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124232_bb0010","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1021\/acs.est.7b06026","article-title":"Bacteria that make a meal of sulfonamide antibiotics: blind spots and emerging opportunities","volume":"52","author":"Deng","year":"2018","journal-title":"Environ. Sci. Technol."},{"issue":"23","key":"10.1016\/j.ijbiomac.2023.124232_bb0015","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1016\/j.bmcl.2012.10.003","article-title":"Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase\/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: optimization of physical properties leading to antibacterial aryl sulfonamides","volume":"22","author":"Stokes","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.124232_bb0020","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.bmcl.2012.03.092","article-title":"A novel pyrimidine derivatives with aryl urea, thiourea and sulfonamide moieties: synthesis, anti-inflammatory and antimicrobial evaluation","volume":"22","author":"Keche","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.124232_bb0025","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ejmech.2007.02.015","article-title":"Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities","volume":"42","author":"da Costa Leite","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0030","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejmech.2014.11.041","article-title":"Design and synthesis of sulfonamide derivatives of pyrrolidine and piperidine as anti-diabetic agents","volume":"90","author":"Sharma","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109956","article-title":"Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease","volume":"360","author":"Bilen","year":"2022","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"28","key":"10.1016\/j.ijbiomac.2023.124232_bb0045","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1021\/ja035776p","article-title":"Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids","volume":"125","author":"Remenar","year":"2003","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124232_bb0050","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bmcl.2014.02.027","article-title":"Design and synthesis of novel 2H-chromen-2-one derivatives bearing 1,2,3-triazole moiety as lead antimicrobials","volume":"24","author":"Kushwaha","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0055","article-title":"1,2,3-Triazole derivatives: synthesis, docking, cytotoxicity analysis and in vivo antimalarial activity","volume":"350","author":"Lopes","year":"2021","journal-title":"Chem.-Biol. Interact."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124232_bb0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"18","key":"10.1016\/j.ijbiomac.2023.124232_bb0065","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.2165\/11596540-000000000-00000","article-title":"Triazole antifungal agents in invasive fungal infections","volume":"71","author":"Lass-Fl\u00f6rl","year":"2011","journal-title":"Drugs"},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.124232_bb0070","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1039\/D1OB00061F","article-title":"Recent advances in the synthesis and reactivity of azetidines: strain-driven character of the four-membered heterocycle","volume":"19","author":"Mughal","year":"2021","journal-title":"Org. Biomol. Chem."},{"issue":"22","key":"10.1016\/j.ijbiomac.2023.124232_bb0075","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1021\/jm020980t","article-title":"Synthesis, antifungal activity, and molecular modeling studies of new inverted oxime ethers of oxiconazole","volume":"45","author":"Rossello","year":"2002","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124232_bb0080","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1007\/s00044-014-0967-3","article-title":"Synthesis of fluorene and\/or benzophenone O-oxime ethers containing amino acid residues and study of their cardiovascular and antibacterial effects","volume":"23","author":"Soltani Rad","year":"2014","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124232_bb0085","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.ejmech.2009.12.041","article-title":"Synthesis and anti-inflammatory activity of novel (substituted)benzylidene acetone oxime ether derivatives: molecular modeling study","volume":"45","author":"El-Gamal","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124232_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ddr.21491","article-title":"Synthesis, anticonvulsant screening, and molecular modeling studies of new arylalkylimidazole oxime ether derivatives","volume":"80","author":"\u00d6zdemir","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0095","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ejmech.2017.12.032","article-title":"Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: preparation and antitumor activity of oximes, oxime ethers and a lactam","volume":"144","author":"V\u00e1gv\u00f6lgyi","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0100","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ijbiomac.2020.09.043","article-title":"Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors","volume":"163","author":"Sever","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124232_bb0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/14756366.2015.1054820","article-title":"The effects of some bromophenols on human carbonic anhydrase isoenzymes","volume":"31","author":"Taslimi","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124232_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/15257770.2018.1562074","article-title":"Interaction of cobalt(II) and copper(II) hydroxamates with polyriboadenylic acid: an insight into RNA based drug designing, nucleosides","volume":"38","author":"Thakur","year":"2019","journal-title":"Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.12.121","article-title":"Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives","volume":"170","author":"Pedrood","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113486","article-title":"Novel benzenesulfonamides aryl and arylsulfone conjugates adopting tail\/dual tail approaches: synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies","volume":"221","author":"Eldeeb","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijbiomac.2016.10.096","article-title":"Novel eugenol derivatives: potent acetylcholinesterase and carbonic anhydrase inhibitors","volume":"94","author":"Topal","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128249","article-title":"Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: design, synthesis, computational and enzyme inhibition studies","volume":"48","author":"Manzoor","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.124232_bb0135","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm0501073","article-title":"Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors","volume":"48","author":"Cecchi","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200554","article-title":"Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif","volume":"356","author":"Demir","year":"2023","journal-title":"Arch. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124232_bb0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon- versus Sulphur-based zinc binding groups for carbonic anhydrase inhibitors?","volume":"33","author":"Supuran","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124232_bb0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.resp.2006.03.007","article-title":"The structure and function of carbonic anhydrase isozymes in the respiratory system of vertebrates","volume":"154","author":"Esbaugh","year":"2006","journal-title":"Resp. Phys. Neurobiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124232_bb0155","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2018.06.021","article-title":"Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors","volume":"155","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0165","first-page":"1","article-title":"Synthesis, characterization and docking studies of benzenesulfonamide derivatives containing 1,2,3-triazole as potential \u0131nhibitor of carbonic anhydrase I-II enzymes","author":"G\u00fcng\u00f6r","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.124232_bb0170","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124232_bb0175","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/14756366.2014.956310","article-title":"Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII)","volume":"30","author":"Scozzafava","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124232_bb0180","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/14756366.2014.999236","article-title":"The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII)","volume":"30","author":"Scozzafava","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.124232_bb0185","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","article-title":"Carbonic anhydrases as targets for medicinal chemistry","volume":"15","author":"Supuran","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110134","article-title":"Synthesis, characterization, evaluation of metabolic enzyme inhibitors and in silico studies of thymol based 2-amino thiol and sulfonic acid compounds","author":"Bora","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134783","article-title":"The synthesis, biological evaluation and in silico studies of asymmetric 3,5-diaryl-rhodanines as novel inhibitors of human carbonic anhydrase isoenzymes","volume":"1276","author":"Yararli","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112219","article-title":"Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes","volume":"193","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124232_bb0205","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"33","key":"10.1016\/j.ijbiomac.2023.124232_bb0210","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1039\/C5CC01854D","article-title":"X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors","volume":"51","author":"Ivanova","year":"2015","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124232_bb0215","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.124232_bb0220","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124232_bb0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117111","article-title":"Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase","volume":"77","author":"Kakakhan","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124232_bb0235","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.124232_bb0240","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expert Opin. Drug Discovery"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124232_bb0245","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3109\/14756366.2015.1128426","article-title":"Synthesis and evaluation of sulfonamide-bearing thiazole as carbonic anhydrase isoforms hCA I and hCA II","volume":"31","author":"K\u0131l\u0131caslan","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/453543","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","volume":"2015","author":"Pinard","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.124232_bb0255","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.3390\/ijms22094931","article-title":"Effective drug concentration and selectivity depends on fraction of primitive cells","volume":"22","author":"Lica","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124232_bb0260","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/jmbi.1994.1655","article-title":"Drug-protein interactions: refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme","volume":"243","author":"Chakravarty","year":"1994","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.124232_bb0265","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1107\/S1744309109036665","article-title":"High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design","volume":"65","author":"Sippel","year":"2009","journal-title":"Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun."},{"issue":"38","key":"10.1016\/j.ijbiomac.2023.124232_bb0270","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. India Sect. A"},{"issue":"17","key":"10.1016\/j.ijbiomac.2023.124232_bb0275","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. India Sect. A"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124232_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.124232_bb0285","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1021\/ja993663t","article-title":"Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water","volume":"122","author":"Duffy","year":"2000","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124232_bb0290","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ijbiomac.2023.124232_bb0295","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103004","article-title":"Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"89","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.124232_bb0305","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1080\/07391102.2020.1736631","article-title":"Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes","volume":"39","author":"T\u00fcrke\u015f","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.124232_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100294","article-title":"Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds","volume":"354","author":"Sever","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200132","article-title":"Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrides as carbonic anhydrase inhibitors","volume":"355","author":"Osmaniye","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103897","article-title":"Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs","volume":"100","author":"Lolak","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2020.121542","article-title":"Mannich reaction derived novel boron complexes with amine-bis(phenolate) ligands: synthesis, spectroscopy and in vitro\/in silico biological studies","volume":"927","author":"Kilic","year":"2020","journal-title":"J. Organomet. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.124232_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23152","article-title":"Methyl benzoate derivatives: in vitro paraoxonase 1 inhibition and in silico studies","volume":"36","author":"Korkmaz","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124232_bb0335","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.124232_bb0340","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1080\/07391102.2021.1916599","article-title":"Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors","volume":"40","author":"T\u00fcrke\u015f","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124232_bb0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"6)","key":"10.1016\/j.ijbiomac.2023.124232_bb0350","article-title":"Analysis of cell viability by the lactate dehydrogenase assay","volume":"2018","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb. Protoc."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124232_bb0355","first-page":"2993","article-title":"Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells","volume":"29","author":"Badisa","year":"2009","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124232_bb0360","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/molecules25081789","article-title":"Synthesis, antiproliferative activity and molecular docking studies of novel doubly modified colchicine amides and sulfonamides as anticancer agents","volume":"25","author":"Krzywik","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124232_bb0365","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/14756366.2020.1746784","article-title":"Synthesis, characterization, biological evaluation and in silico studies of sulfonamide schiff bases","volume":"35","author":"Durgun","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0370","series-title":"Schr\u00f6dinger Release 2022-3: Protein Preparation Wizard","year":"2022"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124232_bb0375","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0380","series-title":"Schr\u00f6dinger Release 2022-3: LigPrep","year":"2022"},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105009","article-title":"Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo [2, 1-b][1, 3, 4] thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors","author":"Askin","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"22","key":"10.1016\/j.ijbiomac.2023.124232_bb0390","doi-asserted-by":"crossref","first-page":"12008","DOI":"10.1080\/07391102.2021.1967195","article-title":"Molecular docking and inhibition studies of vulpinic, carnosic and usnic acids on polyol pathway enzymes","volume":"40","author":"Demir","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0395","series-title":"Schr\u00f6dinger Release 2022-3: Epik","year":"2022"},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.124232_bb0400","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pKaprediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0405","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1515\/chem-2021-0032","article-title":"A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity","volume":"19","author":"Sever","year":"2021","journal-title":"Open Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0410","series-title":"Schr\u00f6dinger Release 2022-3: SiteMap","year":"2022"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124232_bb0415","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0420","series-title":"Schr\u00f6dinger Release 2022-3: Receptor Grid Generation","year":"2022"},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0425","series-title":"Schr\u00f6dinger Release 2022-3: Glide","year":"2022"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124232_bb0430","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124232_bb0435","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0440","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s11030-022-10422-8","article-title":"Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif","volume":"26","author":"G\u00fcle\u00e7","year":"2022","journal-title":"Mol. Divers."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124232_bb0445","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1021\/ci700271z","article-title":"Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB\/SA scoring","volume":"47","author":"Barreiro","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0450","series-title":"Schr\u00f6dinger Release 2022-3: Prime","year":"2022"},{"key":"10.1016\/j.ijbiomac.2023.124232_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105473","article-title":"Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase","volume":"117","author":"Yapar","year":"2021","journal-title":"Bioorg. Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023011261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023011261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:06:10Z","timestamp":1758881170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023011261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":91,"alternative-id":["S0141813023011261"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124232","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124232"}}